merged_alzheimers-blood-test.txt
<question_number>1</question_number>
<answer>No therapies available and risk of anxiety and psychological reactions</answer>
<question_number>2</question_number>
<answer>Approximately 90% versus about 59% accuracy</answer>
<question_number>3</question_number>
<answer>Because many individuals with subjective cognitive decline do not actually have Alzheimerâ€™s</answer>
<question_number>4</question_number>
<answer>Integration of the blood test analysis into hospital laboratory systems instead of relying on outside labs</answer>
<question_number>5</question_number>
<answer>Ptau-217</answer>
<question_number>6</question_number>
<answer>Only for symptomatic patients; for asymptomatic individuals only within research studies</answer>
<question_number>7</question_number>
<answer>Kidney disease</answer>
<question_number>8</question_number>
<answer>It may lead to anxiety and other psychological reactions</answer>
<question_number>9</question_number>
<answer>41%</answer>
<question_number>10</question_number>
<answer>It could increase access to screening in underserved communities</answer>